Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 5”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Large-scale testing (Phase 3)Study completedNCT04526990
What this trial is testing

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Who this might be right for
COVID-19
CanSino Biologics Inc. 44,247
Early research (Phase 1)Ended earlyNCT02751528
What this trial is testing

QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer

Who this might be right for
Cancer
NantBioScience, Inc. 3
Not applicableStudy completedNCT00483028
What this trial is testing

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

Who this might be right for
Alzheimer's Disease
Pfizer 38
Large-scale testing (Phase 3)Study completedNCT04540419
What this trial is testing

Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19

Who this might be right for
Covid19
NPO Petrovax 500
Early research (Phase 1)Study completedNCT04552366
What this trial is testing

A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults

Who this might be right for
COVID-19
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China 149
Early research (Phase 1)Study completedNCT00004779
What this trial is testing

Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
National Center for Research Resources (NCRR) 12
Early research (Phase 1)Study completedNCT00499200
What this trial is testing

Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy

Who this might be right for
Alzheimer's Disease
Wyeth is now a wholly owned subsidiary of Pfizer 42
Large-scale testing (Phase 3)WithdrawnNCT05124561
What this trial is testing

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

Who this might be right for
COVID-19
CanSino Biologics Inc.
Very early researchLooking for participantsNCT04123314
What this trial is testing

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Who this might be right for
Depressive SymptomsDepressionAlzheimer Disease+1 more
Johns Hopkins University 20
Testing effectiveness (Phase 2)Study completedNCT02580305
What this trial is testing

SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study

Who this might be right for
Alzheimer's Disease
Suven Life Sciences Limited 564
Early research (Phase 1)Study completedNCT01972737
What this trial is testing

Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer

Who this might be right for
Colon Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05419011
What this trial is testing

Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome

Who this might be right for
Colorectal CarcinomaColorectal NeoplasmLynch Syndrome
National Cancer Institute (NCI) 186
Early research (Phase 1)Study completedNCT02005991
What this trial is testing

Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377

Who this might be right for
Healthy
Pfizer 4
Testing effectiveness (Phase 2)UnknownNCT04398147
What this trial is testing

Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada

Who this might be right for
COVID-19
CanSino Biologics Inc. 696
Early research (Phase 1)Study completedNCT00964756
What this trial is testing

An Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

Who this might be right for
Ovarian Cancer
University of Alabama at Birmingham 11
Post-approval studies (Phase 4)Study completedNCT04892459
What this trial is testing

Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 300
Testing effectiveness (Phase 2)UnknownNCT02844699
What this trial is testing

Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer

Who this might be right for
Prostate Cancer
Panacela Labs LLC 24
Large-scale testing (Phase 3)Study completedNCT05204589
What this trial is testing

Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 10,285
Large-scale testing (Phase 3)Ended earlyNCT05169008
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents

Who this might be right for
COVID-19
CanSino Biologics Inc. 91
Testing effectiveness (Phase 2)UnknownNCT05330871
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.

Who this might be right for
COVID-19
Seventh Medical Center of PLA General Hospital 410
Load More Results